World Patent WO/2025/264700A1 (2025)
So, is this a perfect tsunami of those two coming together, and these two things of IRA uncertainty, uncertainty with regards to the regulatory issues, with regards to approval process at the FDA, and creating a very huge barrier for not only new drugs coming out, but these labeling extensions that Peter talked about, which is, are we going invest more money to research an existing drug in the market, or were just going to pull back everything
The FDA approved tirzepatide (Zepbound) specifically for weight loss in non-diabetic adults with a BMI of 30 or higher, or 27 or higher with weight-related health conditions
S, puede existir recuperacin de peso tras suspender semaglutida, aunque conviene hablar con precisin: no es que Ozempic engorde al dejarlo, sino que desaparecen parte de los efectos que ayudaban al control del apetito y del peso
But unless theyre as bad at math as he is, theyll realize that this is a huge benefit with little cost in the longer run
The cost of GLP-1 varies depending on many factors, the brand of GLP-1 meds you are prescribed, specific product formulation, provider location, and the extent of your treatment plan
